These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

590 related items for PubMed ID: 8555653

  • 21. TNF-induced apoptosis in multidrug resistant friend erythroleukemia is not influenced by the P-glycoprotein and glutathione status of the cell line.
    Flugy A, Borsellino N, D'Alessandro N.
    Oncol Res; 1995; 7(10-11):559-64. PubMed ID: 8866668
    [Abstract] [Full Text] [Related]

  • 22. Effects of glutathione depletion by buthionine sulfoximine on radiosensitization by oxygen and misonidazole in vitro.
    Shrieve DC, Denekamp J, Minchinton AI.
    Radiat Res; 1985 Jun; 102(3):283-94. PubMed ID: 4070545
    [Abstract] [Full Text] [Related]

  • 23. Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine.
    Jin J, Wang FP, Wei H, Liu G.
    Cancer Chemother Pharmacol; 2005 Feb; 55(2):179-88. PubMed ID: 15378274
    [Abstract] [Full Text] [Related]

  • 24. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
    Ono K, Shrieve DC.
    J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662
    [Abstract] [Full Text] [Related]

  • 25. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
    Liu ZL, Hirano T, Tanaka S, Onda K, Oka K.
    J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
    [Abstract] [Full Text] [Related]

  • 26. Augmentation of cisplatin (DDP) cytotoxicity in vivo by DL-buthionine sulfoximine (BSO) in DDP-sensitive and-resistant rat ovarian tumors and its relation to DNA interstrand cross links.
    Chen G, Zeller WJ.
    Anticancer Res; 1991 Nov; 11(6):2231-7. PubMed ID: 1776864
    [Abstract] [Full Text] [Related]

  • 27. The apoptotic signaling of TNF-alpha in multidrug resistant Friend leukemia cells.
    D'Alessandro N, Flugy A, Tolomeo M, Dusonchet L.
    Anticancer Res; 1998 Nov; 18(4C):3065-72. PubMed ID: 9713511
    [Abstract] [Full Text] [Related]

  • 28. Variable baseline gamma-glutamylcysteine synthetase messenger RNA expression in peripheral mononuclear cells of cancer patients, and its induction by buthionine sulfoximine treatment.
    Yao K, Godwin AK, Ozols RF, Hamilton TC, O'Dwyer PJ.
    Cancer Res; 1993 Aug 15; 53(16):3662-6. PubMed ID: 8101766
    [Abstract] [Full Text] [Related]

  • 29. Reversal of cancer multidrug resistance by green tea polyphenols.
    Mei Y, Qian F, Wei D, Liu J.
    J Pharm Pharmacol; 2004 Oct 15; 56(10):1307-14. PubMed ID: 15482646
    [Abstract] [Full Text] [Related]

  • 30. Effect of cepharanthine on doxorubicin cytotoxicity in P388 murine leukemia cells in vitro and in vivo.
    Fujimura T, Furusawa S, Kawauchi H, Takayanagi Y, Sasaki K.
    Res Commun Chem Pathol Pharmacol; 1991 Feb 15; 71(2):235-8. PubMed ID: 2047569
    [Abstract] [Full Text] [Related]

  • 31. Role of glutathione in the in vitro synergism between 4-hydroperoxy-cyclophosphamide and cisplatin in leukemia cell lines.
    Peters RH, Jollow DJ, Stuart RK.
    Cancer Res; 1991 May 15; 51(10):2536-41. PubMed ID: 2021933
    [Abstract] [Full Text] [Related]

  • 32. Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line.
    Cole SP, Downes HF, Mirski SE, Clements DJ.
    Mol Pharmacol; 1990 Feb 15; 37(2):192-7. PubMed ID: 1968221
    [Abstract] [Full Text] [Related]

  • 33. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
    Liebmann JE, Hahn SM, Cook JA, Lipschultz C, Mitchell JB, Kaufman DC.
    Cancer Res; 1993 May 01; 53(9):2066-70. PubMed ID: 8097674
    [Abstract] [Full Text] [Related]

  • 34. Effects of glutathione depletion using buthionine sulphoximine on the cytotoxicity in mammalian cells and human tumor cells in vitro.
    Jin YZ, Ding L, Shen ZF, Cai RM, Xu LM, Yang JK, Jin XQ, Lu WQ, Xu JF.
    Chin Med J (Engl); 1992 Aug 01; 105(8):647-50. PubMed ID: 1458967
    [Abstract] [Full Text] [Related]

  • 35. L-Buthionine (S,R) sulfoximine depletes hepatic glutathione but protects against ethanol-induced liver injury.
    Donohue TM, Curry-McCoy TV, Todero SL, White RL, Kharbanda KK, Nanji AA, Osna NA.
    Alcohol Clin Exp Res; 2007 Jun 01; 31(6):1053-60. PubMed ID: 17428293
    [Abstract] [Full Text] [Related]

  • 36. The synergistic reversal effect of multidrug resistance by quercetin and hyperthermia in doxorubicin-resistant human myelogenous leukemia cells.
    Shen J, Zhang W, Wu J, Zhu Y.
    Int J Hyperthermia; 2008 Mar 01; 24(2):151-9. PubMed ID: 18283591
    [Abstract] [Full Text] [Related]

  • 37. Influence of buthionine sulfoximine and misonidazole on glutathione level and radiosensitivity of human tumor xenografts.
    Guichard M, Lespinasse F, Malaise EP.
    Radiat Res; 1986 Jan 01; 105(1):115-25. PubMed ID: 3945723
    [Abstract] [Full Text] [Related]

  • 38. Enhancement of murine phenytoin teratogenicity by the gamma-glutamylcysteine synthetase inhibitor L-buthionine-(S,R)-sulfoximine and by the glutathione depletor diethyl maleate.
    Wong M, Helston LM, Wells PG.
    Teratology; 1989 Aug 01; 40(2):127-41. PubMed ID: 2772848
    [Abstract] [Full Text] [Related]

  • 39. Lack of enhanced myelotoxicity with buthionine sulfoximine and sulfhydryl-dependent anticancer agents in mice.
    Soble MJ, Dorr RT.
    Res Commun Chem Pathol Pharmacol; 1987 Feb 01; 55(2):161-80. PubMed ID: 3823607
    [Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics of buthionine sulfoximine (NSC 326231) and its effect on melphalan-induced toxicity in mice.
    Smith AC, Liao JT, Page JG, Wientjes MG, Grieshaber CK.
    Cancer Res; 1989 Oct 01; 49(19):5385-91. PubMed ID: 2766304
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.